Tuberculosis drug development pipeline: progress and hope

Lancet. 2006 Mar 18;367(9514):945-7. doi: 10.1016/S0140-6736(06)68388-8.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Approval
  • Drug Industry
  • Humans
  • Mycobacterium tuberculosis / drug effects*
  • Research
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents